Emergence of inflammatory fibroblasts with aging in Hermansky-Pudlak syndrome associated pulmonary fibrosis
Brandon J. H. Banaschewski(Children's Hospital of Philadelphia), Lisa R. Young(Children's Hospital of Philadelphia), Edward Cantu(Hospital of the University of Pennsylvania), Jason J. Gokey(Vanderbilt University Medical Center), Jarod A. Zepp(Children's Hospital of Philadelphia), Amir Emtiazjoo(University of Florida), Sneha Sitaraman(Children's Hospital of Philadelphia), Jamie L. Todd(Duke University), David B. Frank(Children's Hospital of Philadelphia), Ruby Pan(Children's Hospital of Philadelphia), Maria C. Basil(Boston University), Mary Kate Goldy(Children's Hospital of Philadelphia), Susan M. Lin(Hospital of the University of Pennsylvania), Nigel S. Michki(Children's Hospital of Philadelphia), Jonathan A. Kropski(Vanderbilt University), Joanna Y. Wang(University of Pittsburgh), Jeremy Katzen(Translational Therapeutics (United States))
Cited by 11
Related Papers
Efficacy and Safety of Sirolimus in Lymphangioleiomyomatosis
|New England Journal of Medicine|2011|1.1k
Specialized pro-resolving mediators: endogenous regulators of infection and inflammation
|Nature reviews. Immunology|2015|758
Clinical Risk Factors for Primary Graft Dysfunction after Lung Transplantation
|American Journal of Respiratory and Critical Care Medicine|2013|686
The Cellular and Physiological Basis for Lung Repair and Regeneration: Past, Present, and Future
|Cell stem cell|2020|419